Author

F. Russo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Approach:biophysical modeling· 1 Research Focus:development & morphogenesis· 1 Assay:imaging· 1 Assay:metabolomics· 1 Organism:rat· 1

Frequent Co-Authors

A. Alhendi· 1 shared A. Dos Santos Dias· 1 shared A. Khabbush· 1 shared A. Luini· 1 shared A. P. Bowman· 1 shared A. Tedeschi· 1 shared B. Spengler· 1 shared C. Fachin· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Alhendi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Prenatal VEGF Nano-Delivery Reverses Congenital Diaphragmatic Hernia-Associated Pulmonary Abnormalities

S. Loukogeorgakis, F. Michielin, S. Shibuya, N. Al-Juffali, J. Jimenez, J. Allen-Hyttinen, P. Eastwood, A. Alhendi, J. Davidson, E. Naldi, P. Maghsoudlou, A. Tedeschi, S. Khalaf, A. Khabbush, M. Plate, , P. De Coppi

This paper investigates VEGF supplementation as a treatment for congenital diaphragmatic hernia (CDH)-associated lung abnormalities using an ex vivo model and nanoparticle-based delivery in vivo.

bioRxiv · Feb 20, 2024Bioengineering

Prioritization of driver genes in cancer-associated copy number alterations identifies B4GALT5 as a glycooncogene

S. Parashuraman, P. Sahu, F. Russo, I. Agliarulo, R. Rizzo, M. Lo Monte, N. Normanno, S. Soddu, F. Carlomagno, A. Luini

The paper identifies B4GALT5 as a glyco-oncogene by analyzing copy number alterations in glycosylation regulator genes across cancer datasets.

bioRxiv · Mar 30, 2022 · PreprintCancer Biology

Sphingolipid Control of Fibroblast Heterogeneity Revealed by Single-Cell Lipidomics

L. Capolupo, I. Khven, L. Mazzeo, G. Glousker, F. Russo, J. Paz Montoya, S. Ho, D. R. Bhandari, A. P. Bowman, S. Ellis, R. Guiet, J. Muthing, B. Spengler, R. M. A. Heeren, G.-P. Dotto, , G. D'Angelo

This study identifies sphingolipid composition as a driver of fibroblast heterogeneity and state transitions using single-cell lipidomics and transcriptomics.

bioRxiv · Feb 23, 2021 · PreprintBiochemistry